aclidinium vs indacaterol
Side-by-side comparison of aclidinium and indacaterol Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Tudorza Pressair
Arcapta Neohaler
Duaklir Pressair is a combination medicine used to help people with COPD breathe better. It contains two medicines that open up the airways in your lungs.
UTIBRON NEOHALER is a medicine that helps people with COPD breathe easier. It contains two medicines that work together to open up your airways.
Duaklir Pressair is used to treat chronic obstructive pulmonary disease (COPD). COPD is a long-term lung disease that makes it hard to breathe. This medicine helps to open the airways and make it easier to breathe for people with COPD.
UTIBRON NEOHALER is used long-term to treat airflow blockage caused by COPD. COPD is a chronic lung disease that makes it hard to breathe. This medicine helps to open your airways so you can breathe easier. It is not for sudden breathing problems.
Duaklir Pressair contains two medicines that work in different ways. One medicine relaxes the muscles around your airways, opening them up. The other medicine prevents the muscles from tightening.
UTIBRON NEOHALER has two medicines. Indacaterol opens airways by relaxing airway muscles. Glycopyrrolate reduces airway tightening. Together, they help you breathe easier.
- • Upper respiratory infection
- • Headache
- • Back pain
- • Common cold symptoms (nasopharyngitis)
- • High blood pressure (hypertension)
- Difficulty breathing 1,869
- Inhaler not working correctly 1,281
- Skipped a dose of medicine 1,017
- Asthma 814
- Chronic obstructive pulmonary disease (COPD) 764
No adverse event reports.
LABAs, such as formoterol fumarate, one of the active ingredients in DUAKLIR PRESSAIR, increase the risk of asthma-related death. Duaklir Pressair is not for asthma. Do not use Duaklir Pressair if you are allergic to milk proteins or any of the ingredients in it. Tell your doctor if you have heart problems, glaucoma, trouble urinating, diabetes, or seizures.
LABA medicines like UTIBRON NEOHALER can raise the risk of asthma-related death. Because of this risk, you should not take this medication if you have asthma. Do not use UTIBRON NEOHALER to treat sudden COPD symptoms. Do not use with other LABA medicines.
It is not known if Duaklir Pressair will harm an unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is also not known if this medicine passes into breast milk. Talk to your doctor about the best way to feed your baby if you are taking Duaklir Pressair.
Tell your doctor if you are pregnant or plan to become pregnant. It is not known if UTIBRON NEOHALER will harm your unborn baby. Talk to your doctor about the risks and benefits of using this medicine while pregnant.
Also Compare — Nearby Drugs
Compare aclidinium with
Compare indacaterol with
How to Read This aclidinium vs indacaterol Comparison
aclidinium is classified in the Long-Acting Muscarinic Antagonist (LAMA) drug class, while indacaterol sits within the Long-Acting Beta-2 Agonist (LABA) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, aclidinium has 5,745 submissions while indacaterol has 0. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between aclidinium and indacaterol — always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.